Dr. Gehrig is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1240 Lee Street
PO Box 800712
Charlottesville, VA 22908Phone+1 434-924-9937Fax+1 434-982-1840- Is this information wrong?
Summary
- Dr. Paola Gehrig is the Chair of Obstetrics and Gynecology at the University of Virginia and is a practicing surgeon in the Division of Gynecologic Oncology. She received her medical degree from University of Florida College of Medicine and has been in practice 25 years. She specializes in gynecologic oncology and is experienced in general obstetrics and gynecology, hysterectomy, gynecologic oncology, and minimally invasive gynecologic surgery.
Education & Training
- University of North Carolina HospitalsFellowship, Gynecologic Oncology, 1997 - 2000
- University of Virginia Medical CenterResidency, Obstetrics and Gynecology, 1993 - 1997
- University of Florida College of MedicineClass of 1993
Certifications & Licensure
- VA State Medical License 2022 - 2026
- NC State Medical License 1997 - 2023
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
- Fellow (FACOG) American Congress of Obstetricians and Gynecologists
- Fellow (FACS) American College of Surgeons
Clinical Trials
- Trisenox® in Women With Metastatic Endometrial Cancer Start of enrollment: 2010 Mar 01
- Evaluation of Carboplatin/Paclitaxel With and Without Trastuzumab (Herceptin) in Uterine Serous Cancer Start of enrollment: 2011 Jun 01
- Hybrid PET/MR in the Therapy of Cervical Cancer Start of enrollment: 2012 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- 106 citationsMetformin potentiates the effects of paclitaxel in endometrial cancer cells through inhibition of cell proliferation and modulation of the mTOR pathway.Rabbie K. Hanna, Chunxiao Zhou, Kimberly M. Malloy, Li Sun, Yan Zhong
Gynecologic Oncology. 2012-05-01 - 25 citationsSarcopenia as a predictor of survival and chemotoxicity in patients with epithelial ovarian cancer receiving platinum and taxane-based chemotherapyS. Allison Staley, Katherine L. Tucker, Meredith Newton, Michelle Ertel, Jorge Oldan
Gynecologic Oncology. 2020-03-01 - 310 citationsA comparative study of 3 surgical methods for hysterectomy with staging for endometrial cancer: robotic assistance, laparoscopy, laparotomyJohn F. Boggess, Paola A. Gehrig, Leigh A. Cantrell, Aaron Shafer, Mildred Ridgway
American Journal of Obstetrics and Gynecology. 2008-10-01
Journal Articles
- Survival Advantage Associated with Multimodal Therapy in Women with Node‐Positive (Stage‐IIIC) Uterine Papillary Serous Carcinoma: A National Cancer Database StudyJ F Lin, K Muniz, P Gehrig, R P Edwards, A B Olawaiye, S Beriwal, P Sukumvanich, J L Kelley, BJOG: An International Journal of Obstetrics & Gynaecology
Press Mentions
- What Does the Link Between Hair Relaxers & Uterine Cancer Mean for Black Women?March 9th, 2023
- 7 Quick Questions with Gynecologic Cancer Doctor Paola GehrigAugust 3rd, 2022
- Dr. Paola a. Gehrig to Chair UVA Department of Obstetrics and GynecologyFebruary 11th, 2022
- Join now to see all
Professional Memberships
- Member
- Member
- Society of Gynecologic OncologyMember
- Fellow
- Member
Other Languages
- Spanish
Hospital Affiliations
- University of Virginia Medical CenterCharlottesville, Virginia
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: